Alma Hybrid

Name: Alma Hybrid
Brand: Alma

CO2 Fractional/Ablative · CO2 10600nm + 1570nm fiber hybrid

Work at Alma? — one claim covers all 13 of your devices.

CurrentFDA status under verificationBe the first to review

The Alma Hybrid typically sells new in the $120k–$160k range in the US, with used and refurbished systems around $70k–$100k. Alma Hybrid's FDA status is under verification by our research team. Figures are market estimates verified August 6, 2026.

Last verified: August 6, 2026 · How we verify

New: $120k–$160k|Used: $70k–$100kmarket estimate, no email required

Key facts
Manufacturer	Alma
Company	Owner: Sisram Medical Ltd (HKEx: 1696), controlled by Shanghai Fosun Pharmaceutical (subsidiary, since 2013) · Distribution: direct
Category	Resurfacing, Tattoo & Vascular
Technology	CO2 10600nm + 1570nm fiber hybrid
FDA status	FDA status under verification
New price range	$120k–$160k
Used price range	$70k–$100k
Consumables	Not published
Launch year	2021
Last verified	August 6, 2026

Save device

Bottom line

A genuinely clever pitch: fire ablative CO2 and non-ablative 1570nm through the same handpiece in one pass, dialing the ratio to trade results against downtime per patient. Near-CO2 outcomes with shorter social recovery — exactly what the 2026 patient wants. The hesitations are practical: ~$150K-200K price, a thin US install base, a nearly nonexistent used market, and Alma's mixed US service reputation. Strong device for a differentiated resurfacing practice; risky as your first big laser.

Overview

Simultaneous ablative/non-ablative HyGrid handpiece

How it works

The science

Three energy sources: a 10,600nm CO2 (vaporizes tissue — the corrective heavy lifter), a 1570nm fiber laser (heats dermal columns without removing skin — the collagen stimulator with minimal downtime), and an ultrasound module (IMPACT) that pushes topicals into freshly-made channels. The HyGrid handpiece interlaces CO2 and 1570nm micro-spots in a single grid — one pass delivers, say, 30% ablative and 70% non-ablative injury. Treats wrinkles, acne and surgical scars, sun damage and laxity with recovery tunable from a weekend to a week. Conceptually HALO's hybrid logic with CO2 instead of erbium — deeper thermal effect, more downtime headroom at the top end.

Patented tech

HyGrid is the real proprietary piece — co-registered dual-wavelength delivery in one scan pattern rather than two sequential passes; IMPACT ultrasound-assisted delivery is carried over from Alma's surgical line.

Origin

Caesarea, Israel (Alma Lasers; parent Sisram Medical/Fosun Pharma).

FDA & regulatory status

FDA status under verificationRegulatory status under verification

FDA status under verification — see our FDA guide. We do not publish an indication or a clearance number for this profile until the record is confirmed against the FDA database.

Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.

Treatment economics

What practices charge

~$1,200-2,500 per session depending on blend intensity, usually 1-3 treatments; lighter "hybrid glow" passes ~$700-1,000 sold in pairs are the volume play.

Consumables & recurring cost

No meaningful per-treatment consumables for laser modes; IMPACT topicals and disposables add ~$20-60 per case where used.

Ideal for

Best-fit practice

Established resurfacing practices — derm, plastics, laser-focused medspas — wanting a marketing edge over the ubiquitous HALO, feeding 45-65-year-old correction patients plus downtime-averse 35+ maintenance patients. Not for practices without a physician culture around ablative work.

Compliance

Medical director & delegation

Class II prescription device; the CO2 side puts it in physician/NP-PA territory in most states even when the 1570nm-only modes could be delegated.

Contraindications & screening

Standard ablative screening — recent isotretinoin, active infection/herpes, keloids, pregnancy; darker Fitzpatrick types need conservative CO2 fractions and pigment priming.

Ownership

Warranty & service

~1 year standard, extended ~$10K-20K/year; Alma's US coverage has improved but is thinner than Sciton's — get response-time commitments in the contract.

Resale & used market

Weak for now — too few US units for a liquid secondary market; expect steep first-owner depreciation and plan to hold 5+ years.

Chains using this device

No confirmed chain deployments recorded yet.

Owner reviews

Write a review

No verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.